Corey Cutler (@drccutler) 's Twitter Profile
Corey Cutler

@drccutler

Director, Stem Cell Transplant Program @DanaFarber Cancer Institute.
President @ASTCT. Tweets are my own and not medical advice.

ID: 2851552811

linkhttp://dana-farber.org calendar_today30-10-2014 15:39:14

1,1K Tweet

2,2K Followers

375 Following

ASTCT (@astct) 's Twitter Profile Photo

Calling all APPs, nurses, fellows & in-training professionals! Gain a deeper understanding of diagnostic evaluations & treatments for acute & chronic complications of #HSCT & cellular therapies at the Clinical Education Conference. Register now: ow.ly/jUog50SuUlC #CEC24

Calling all APPs, nurses, fellows & in-training professionals! Gain a deeper understanding of diagnostic evaluations & treatments for acute & chronic complications of #HSCT & cellular therapies at the Clinical Education Conference. Register now: ow.ly/jUog50SuUlC #CEC24
ASTCT (@astct) 's Twitter Profile Photo

The Clinical Research Training Course in Park City, Utah has officially kicked off! This in-person course allows scholars to present their research and work closely with course faculty throughout the week. Learn more: ow.ly/7JCl50SA2Ov #CRTC24

The Clinical Research Training Course in Park City, Utah has officially kicked off! This in-person course allows scholars to present their research and work closely with course faculty throughout the week. Learn more: ow.ly/7JCl50SA2Ov #CRTC24
Krishna Komanduri, MD, FASTCT (@drkomanduri) 's Twitter Profile Photo

Exhausted but filled with gratitude after the ASTCT Clinical Research Training Course. A week spent with some of the most talented faculty in the field of #celltherapy and a gifted class of scholars who will replace us and advance our field. What a special community! 🙏🏽🥰🩺

Exhausted but filled with gratitude after the <a href="/ASTCT/">ASTCT</a> Clinical Research Training Course. 

A week spent with some of the most talented faculty in the field of #celltherapy and a gifted class of scholars who will replace us and advance our field.

What a special community! 🙏🏽🥰🩺
Corey Cutler (@drccutler) 's Twitter Profile Photo

Our therapies are of no value unless we can get them into those that need them the most. Congratulations to the #ACCESSInitiative planners and members for continuing to address disparities in the delivery of #BMT and #CellTherapy

Corey Cutler (@drccutler) 's Twitter Profile Photo

Tomorrow, I will start a 2-day, 160 mile Pan-Mass Challenge challenge bike ride to support innovative cancer research at Dana-Farber . Want to support my ride? Donate here: pmc.org/cc0369 Thanks!

Corey Cutler (@drccutler) 's Twitter Profile Photo

What a fantastic 2 days of riding the Pan-Mass Challenge Challenge. 160 miles 10 hours in the saddle All to support cancer research at Dana-Farber Thank you to all that have donated pmc.org/cc0369

What a fantastic 2 days of riding the <a href="/PanMass/">Pan-Mass Challenge</a> Challenge.
160 miles
10 hours in the saddle
All to support cancer research at <a href="/DanaFarber/">Dana-Farber</a>
Thank you to all that have donated 
pmc.org/cc0369
ASTCT (@astct) 's Twitter Profile Photo

The ASTCT New Investigator Awards encourage clinical/lab research by young investigators in #HCT/cell therapy. The award provides $50,000 per year for 2 years in support of research costs/salary. Apply now or share this opportunity: ow.ly/9iIH50SCL0S

The ASTCT New Investigator Awards encourage clinical/lab research by young investigators in #HCT/cell therapy. The award provides $50,000 per year for 2 years in support of research costs/salary. Apply now or share this opportunity: ow.ly/9iIH50SCL0S
ASTCT (@astct) 's Twitter Profile Photo

ASTCT applauds the U.S. FDA approval of Niktimvo (axatilimab-csfr), a significant new therapy for patients suffering from cGVHD. ASTCT President Corey Cutler served as co-first author on the supporting AGAVE-201 study. Read the full press release: ow.ly/lZVr50SY42j

ASTCT applauds the <a href="/US_FDA/">U.S. FDA</a> approval of Niktimvo (axatilimab-csfr), a significant new therapy for patients suffering from cGVHD. ASTCT President <a href="/DrCCutler/">Corey Cutler</a> served as co-first author on the supporting AGAVE-201 study. Read the full press release: ow.ly/lZVr50SY42j
ASTCT (@astct) 's Twitter Profile Photo

📢 Calling all gene therapy professionals! Don’t miss the ASTCT Gene Therapy Summit on Nov 5-6, 2024, at Harvard Medical Conference Center. Learn from and network with experts in the field. Register now: ow.ly/zE3B50SMBTk

📢 Calling all gene therapy professionals! Don’t miss the ASTCT Gene Therapy Summit on Nov 5-6, 2024, at Harvard Medical Conference Center. Learn from and network with experts in the field. Register now: ow.ly/zE3B50SMBTk
ASTCT (@astct) 's Twitter Profile Photo

ASTCT board president Corey Cutler and board member Alan Hanash meet with Chuck Schumer staff to discuss Accelerating Kids’ Access to Care Act and other key issues.

ASTCT board president <a href="/DrCCutler/">Corey Cutler</a> and board member Alan Hanash meet with 
<a href="/SenSchumer/">Chuck Schumer</a>  staff to discuss Accelerating Kids’ Access to Care Act and other key issues.
ASTCT (@astct) 's Twitter Profile Photo

ASTCT and NMDP Advocacy are meeting with Senate and Congressional staff to discuss: - Accelerating Kids Access to Care Act - Alleviating Barriers to Caregivers Act - Medicaid mandate for out-of-state Medicare enrollee benefit NIH funding #ASTCTHillDay

ASTCT and <a href="/NMDP_advocacy/">NMDP Advocacy</a> are meeting with Senate and Congressional staff to discuss: 
- Accelerating Kids Access to Care Act
- Alleviating Barriers to Caregivers Act
- Medicaid mandate for out-of-state Medicare enrollee benefit
<a href="/NIH/">NIH</a> funding 
#ASTCTHillDay
ASTCT (@astct) 's Twitter Profile Photo

We are very appreciative of all the Senate and Congressional staffers who took time out of their day to meet with ASTCT to discuss important funding and patient access initiatives. #ASTCTHillDay

We are very appreciative of all the Senate and Congressional staffers who took time out of their day to meet with ASTCT to discuss important funding and patient access initiatives. 
#ASTCTHillDay
ASTCT (@astct) 's Twitter Profile Photo

ASTCT and CIBMTR are excited to announce that registration is now open for #Tandem2025! Register now to join us Feb. 12-15, 2025, for four days of scientific updates, clinical trials, groundbreaking research and more. See you in Hawaii 🌺🏝️🐬 tandemmeetings.com

ASTCT and <a href="/CIBMTR/">CIBMTR</a> are excited to announce that registration is now open for #Tandem2025! Register now to join us Feb. 12-15, 2025, for four days of scientific updates, clinical trials, groundbreaking research and more. See you in Hawaii 🌺🏝️🐬 tandemmeetings.com